SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 15,980.73 |
| Enterprise Value ($M) | 20,157.20 |
| Book Value ($M) | 3,436.07 |
| Book Value / Share | 2.70 |
| Price / Book | 4.65 |
| NCAV ($M) | 1,319.36 |
| NCAV / Share | 1.04 |
| Price / NCAV | 12.11 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.57 |
| Return on Assets (ROA) | -1.03 |
| Return on Equity (ROE) | -1.69 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.71 |
| Current Ratio | 3.06 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 3,714.15 |
| Assets | 5,830.86 |
| Liabilities | 2,394.79 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| AZNCF – AstraZeneca PLC | BCHMF – Bachem Holding AG |
| BDPT – BioAdaptives, Inc. | BGMD – BG Medicine, Inc. |
| BGXX – Bright Green Corporation |
Financial data and stock pages provided by
Fintel.io